CYduct Diagnostics, Inc.

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SMMNY has a market cap of 125.8B. Regarding current trading prices, CYDX is priced at $0.25, while SMMNY trades at $28.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SMMNY's P/E ratio is 25.04. In terms of profitability, CYDX's ROE is +0.17%, compared to SMMNY's ROE of +0.12%. Regarding short-term risk, CYDX is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check SMMNY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SEMHF has a market cap of 63.7B. Regarding current trading prices, CYDX is priced at $0.25, while SEMHF trades at $56.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SEMHF's P/E ratio is 25.26. In terms of profitability, CYDX's ROE is +0.17%, compared to SEMHF's ROE of +0.12%. Regarding short-term risk, CYDX is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check SEMHF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, RYLPF has a market cap of 25.7B. Regarding current trading prices, CYDX is priced at $0.25, while RYLPF trades at $27.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas RYLPF's P/E ratio is 142.53. In terms of profitability, CYDX's ROE is +0.17%, compared to RYLPF's ROE of +0.01%. Regarding short-term risk, CYDX is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check RYLPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SONVY has a market cap of 17.3B. Regarding current trading prices, CYDX is priced at $0.25, while SONVY trades at $58.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SONVY's P/E ratio is 25.95. In terms of profitability, CYDX's ROE is +0.17%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, CYDX is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check SONVY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SONVF has a market cap of 17.3B. Regarding current trading prices, CYDX is priced at $0.25, while SONVF trades at $290.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SONVF's P/E ratio is 25.92. In terms of profitability, CYDX's ROE is +0.17%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, CYDX and SONVF have similar daily volatility (0.00).Check SONVF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SNNUF has a market cap of 15.1B. Regarding current trading prices, CYDX is priced at $0.25, while SNNUF trades at $17.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SNNUF's P/E ratio is 30.89. In terms of profitability, CYDX's ROE is +0.17%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, CYDX is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check SNNUF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CHEOY has a market cap of 12.9B. Regarding current trading prices, CYDX is priced at $0.25, while CHEOY trades at $97.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CHEOY's P/E ratio is 51.28. In terms of profitability, CYDX's ROE is +0.17%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, CYDX is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CHEOY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CHEOF has a market cap of 12B. Regarding current trading prices, CYDX is priced at $0.25, while CHEOF trades at $183.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CHEOF's P/E ratio is 47.67. In terms of profitability, CYDX's ROE is +0.17%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, CYDX is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CHEOF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, WILYY has a market cap of 8.5B. Regarding current trading prices, CYDX is priced at $0.25, while WILYY trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas WILYY's P/E ratio is 19.58. In terms of profitability, CYDX's ROE is +0.17%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, CYDX is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check WILYY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, WILLF has a market cap of 8.2B. Regarding current trading prices, CYDX is priced at $0.25, while WILLF trades at $40.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas WILLF's P/E ratio is 20.69. In terms of profitability, CYDX's ROE is +0.17%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, CYDX and WILLF have similar daily volatility (0.00).Check WILLF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, GNGBY has a market cap of 6B. Regarding current trading prices, CYDX is priced at $0.25, while GNGBY trades at $21.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas GNGBY's P/E ratio is 38.39. In terms of profitability, CYDX's ROE is +0.17%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, CYDX is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check GNGBY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, GNGBF has a market cap of 5.7B. Regarding current trading prices, CYDX is priced at $0.25, while GNGBF trades at $21.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas GNGBF's P/E ratio is 36.84. In terms of profitability, CYDX's ROE is +0.17%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, CYDX is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check GNGBF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, AMBBY has a market cap of 4.2B. Regarding current trading prices, CYDX is priced at $0.25, while AMBBY trades at $15.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas AMBBY's P/E ratio is 72.05. In terms of profitability, CYDX's ROE is +0.17%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, CYDX and AMBBY have similar daily volatility (0.00).Check AMBBY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, AMBFF has a market cap of 4.1B. Regarding current trading prices, CYDX is priced at $0.25, while AMBFF trades at $15.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas AMBFF's P/E ratio is 72.90. In terms of profitability, CYDX's ROE is +0.17%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, CYDX and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, CYDX is priced at $0.25, while NHNKY trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas NHNKY's P/E ratio is 19.30. In terms of profitability, CYDX's ROE is +0.17%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, CYDX is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check NHNKY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, MCRPF has a market cap of 3.3B. Regarding current trading prices, CYDX is priced at $0.25, while MCRPF trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas MCRPF's P/E ratio is -15.00. In terms of profitability, CYDX's ROE is +0.17%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, CYDX is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check MCRPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, GNNDY has a market cap of 2.7B. Regarding current trading prices, CYDX is priced at $0.25, while GNNDY trades at $56.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas GNNDY's P/E ratio is 21.64. In terms of profitability, CYDX's ROE is +0.17%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, CYDX is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check GNNDY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, GGNDF has a market cap of 2.6B. Regarding current trading prices, CYDX is priced at $0.25, while GGNDF trades at $17.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas GGNDF's P/E ratio is 20.56. In terms of profitability, CYDX's ROE is +0.17%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, CYDX is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check GGNDF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, CYDX is priced at $0.25, while NHNKF trades at $15.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, CYDX's ROE is +0.17%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, CYDX is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check NHNKF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, OSSFF has a market cap of 2B. Regarding current trading prices, CYDX is priced at $0.25, while OSSFF trades at $4.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas OSSFF's P/E ratio is 28.24. In terms of profitability, CYDX's ROE is +0.17%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, CYDX is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check OSSFF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, CYDX is priced at $0.25, while STSEY trades at $6.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas STSEY's P/E ratio is 39.41. In terms of profitability, CYDX's ROE is +0.17%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, CYDX and STSEY have similar daily volatility (0.00).Check STSEY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, CYDX is priced at $0.25, while VTRLY trades at $14.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas VTRLY's P/E ratio is 42.80. In terms of profitability, CYDX's ROE is +0.17%, compared to VTRLY's ROE of +0.03%. Regarding short-term risk, CYDX is less volatile compared to VTRLY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check VTRLY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, CYDX is priced at $0.25, while DWRKF trades at $543.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, CYDX's ROE is +0.17%, compared to DWRKF's ROE of N/A. Regarding short-term risk, CYDX and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, CYDX is priced at $0.25, while OSSUY trades at $4.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, CYDX's ROE is +0.17%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, CYDX and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, CYDX is priced at $0.25, while MEDGF trades at $83.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, CYDX's ROE is +0.17%, compared to MEDGF's ROE of +0.21%. Regarding short-term risk, CYDX and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, CYDX is priced at $0.25, while DRWKF trades at $67.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas DRWKF's P/E ratio is 9.40. In terms of profitability, CYDX's ROE is +0.17%, compared to DRWKF's ROE of +0.07%. Regarding short-term risk, CYDX is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check DRWKF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, DGWPF has a market cap of 1.1B. Regarding current trading prices, CYDX is priced at $0.25, while DGWPF trades at $57.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas DGWPF's P/E ratio is 9.24. In terms of profitability, CYDX's ROE is +0.17%, compared to DGWPF's ROE of +0.07%. Regarding short-term risk, CYDX is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check DGWPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, CYDX is priced at $0.25, while LFTSF trades at $0.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, CYDX's ROE is +0.17%, compared to LFTSF's ROE of +0.06%. Regarding short-term risk, CYDX and LFTSF have similar daily volatility (0.00).Check LFTSF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ELEAF has a market cap of 1B. Regarding current trading prices, CYDX is priced at $0.25, while ELEAF trades at $12.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ELEAF's P/E ratio is 14.07. In terms of profitability, CYDX's ROE is +0.17%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, CYDX is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check ELEAF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, CYDX is priced at $0.25, while MDRSF trades at $66.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, CYDX's ROE is +0.17%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, CYDX is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check MDRSF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, XVIPF has a market cap of 646.9M. Regarding current trading prices, CYDX is priced at $0.25, while XVIPF trades at $20.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas XVIPF's P/E ratio is 55.50. In terms of profitability, CYDX's ROE is +0.17%, compared to XVIPF's ROE of +0.05%. Regarding short-term risk, CYDX is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check XVIPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, CYDX is priced at $0.25, while AVMR trades at $9.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas AVMR's P/E ratio is -18.34. In terms of profitability, CYDX's ROE is +0.17%, compared to AVMR's ROE of -0.92%. Regarding short-term risk, CYDX and AVMR have similar daily volatility (0.00).Check AVMR's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CALZF has a market cap of 475.6M. Regarding current trading prices, CYDX is priced at $0.25, while CALZF trades at $0.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CALZF's P/E ratio is 68.84. In terms of profitability, CYDX's ROE is +0.17%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, CYDX and CALZF have similar daily volatility (0.00).Check CALZF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, CYDX is priced at $0.25, while CLVSF trades at $19.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, CYDX's ROE is +0.17%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, CYDX is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CLVSF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, IOBCF has a market cap of 388.2M. Regarding current trading prices, CYDX is priced at $0.25, while IOBCF trades at $13.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas IOBCF's P/E ratio is 35.81. In terms of profitability, CYDX's ROE is +0.17%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, CYDX is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check IOBCF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CSSPF has a market cap of 384.4M. Regarding current trading prices, CYDX is priced at $0.25, while CSSPF trades at $0.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, CYDX's ROE is +0.17%, compared to CSSPF's ROE of +0.05%. Regarding short-term risk, CYDX is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CSSPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, CYDX is priced at $0.25, while HYBT trades at $0.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas HYBT's P/E ratio is N/A. In terms of profitability, CYDX's ROE is +0.17%, compared to HYBT's ROE of +0.00%. Regarding short-term risk, CYDX and HYBT have similar daily volatility (0.00).Check HYBT's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, EAPIF has a market cap of 293.9M. Regarding current trading prices, CYDX is priced at $0.25, while EAPIF trades at $3.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas EAPIF's P/E ratio is -2.02. In terms of profitability, CYDX's ROE is +0.17%, compared to EAPIF's ROE of -0.14%. Regarding short-term risk, CYDX is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check EAPIF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, CYDX is priced at $0.25, while HTLZF trades at $1.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, CYDX's ROE is +0.17%, compared to HTLZF's ROE of -0.04%. Regarding short-term risk, CYDX and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CYBQY has a market cap of 238.1M. Regarding current trading prices, CYDX is priced at $0.25, while CYBQY trades at $1.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CYBQY's P/E ratio is -66.75. In terms of profitability, CYDX's ROE is +0.17%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, CYDX is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CYBQY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, BCCOY has a market cap of 225.8M. Regarding current trading prices, CYDX is priced at $0.25, while BCCOY trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas BCCOY's P/E ratio is -5.33. In terms of profitability, CYDX's ROE is +0.17%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, CYDX is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check BCCOY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, BRSYF has a market cap of 207.5M. Regarding current trading prices, CYDX is priced at $0.25, while BRSYF trades at $5.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas BRSYF's P/E ratio is 39.21. In terms of profitability, CYDX's ROE is +0.17%, compared to BRSYF's ROE of +0.09%. Regarding short-term risk, CYDX and BRSYF have similar daily volatility (0.00).Check BRSYF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, IMPZY has a market cap of 198.4M. Regarding current trading prices, CYDX is priced at $0.25, while IMPZY trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, CYDX's ROE is +0.17%, compared to IMPZY's ROE of -15.79%. Regarding short-term risk, CYDX and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CLLKF has a market cap of 196.2M. Regarding current trading prices, CYDX is priced at $0.25, while CLLKF trades at $2.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CLLKF's P/E ratio is -4.73. In terms of profitability, CYDX's ROE is +0.17%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, CYDX and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, PXMBF has a market cap of 182.1M. Regarding current trading prices, CYDX is priced at $0.25, while PXMBF trades at $3.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, CYDX's ROE is +0.17%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, CYDX and PXMBF have similar daily volatility (0.00).Check PXMBF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, CYDX is priced at $0.25, while DTXMF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, CYDX's ROE is +0.17%, compared to DTXMF's ROE of -0.45%. Regarding short-term risk, CYDX is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check DTXMF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, EKDHF has a market cap of 175.1M. Regarding current trading prices, CYDX is priced at $0.25, while EKDHF trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas EKDHF's P/E ratio is 19.50. In terms of profitability, CYDX's ROE is +0.17%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, CYDX and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CYBQF has a market cap of 172.8M. Regarding current trading prices, CYDX is priced at $0.25, while CYBQF trades at $1.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CYBQF's P/E ratio is -64.75. In terms of profitability, CYDX's ROE is +0.17%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, CYDX is less volatile compared to CYBQF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CYBQF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, DMTRF has a market cap of 168.4M. Regarding current trading prices, CYDX is priced at $0.25, while DMTRF trades at $1.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas DMTRF's P/E ratio is -8.82. In terms of profitability, CYDX's ROE is +0.17%, compared to DMTRF's ROE of -0.65%. Regarding short-term risk, CYDX is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check DMTRF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, FDMDF has a market cap of 136.3M. Regarding current trading prices, CYDX is priced at $0.25, while FDMDF trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas FDMDF's P/E ratio is -4.18. In terms of profitability, CYDX's ROE is +0.17%, compared to FDMDF's ROE of -0.51%. Regarding short-term risk, CYDX is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check FDMDF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, AVHHL has a market cap of 128.4M. Regarding current trading prices, CYDX is priced at $0.25, while AVHHL trades at $0.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas AVHHL's P/E ratio is -2.08. In terms of profitability, CYDX's ROE is +0.17%, compared to AVHHL's ROE of +279.91%. Regarding short-term risk, CYDX is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check AVHHL's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, CYDX is priced at $0.25, while AMEUF trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, CYDX's ROE is +0.17%, compared to AMEUF's ROE of -2.19%. Regarding short-term risk, CYDX is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check AMEUF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SNZZF has a market cap of 110.9M. Regarding current trading prices, CYDX is priced at $0.25, while SNZZF trades at $0.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SNZZF's P/E ratio is -7.05. In terms of profitability, CYDX's ROE is +0.17%, compared to SNZZF's ROE of -0.39%. Regarding short-term risk, CYDX is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check SNZZF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, CYDX is priced at $0.25, while VMTHF trades at $0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, CYDX's ROE is +0.17%, compared to VMTHF's ROE of -0.29%. Regarding short-term risk, CYDX is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check VMTHF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, CYDX is priced at $0.25, while JMDMF trades at $3.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, CYDX's ROE is +0.17%, compared to JMDMF's ROE of N/A. Regarding short-term risk, CYDX is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check JMDMF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, SOMNF has a market cap of 96M. Regarding current trading prices, CYDX is priced at $0.25, while SOMNF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas SOMNF's P/E ratio is -14.67. In terms of profitability, CYDX's ROE is +0.17%, compared to SOMNF's ROE of -0.20%. Regarding short-term risk, CYDX is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check SOMNF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, CYDX is priced at $0.25, while RSHUF trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, CYDX's ROE is +0.17%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, CYDX is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check RSHUF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, CYDX is priced at $0.25, while CKMTF trades at $12.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, CYDX's ROE is +0.17%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, CYDX and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, IPDQF has a market cap of 50.7M. Regarding current trading prices, CYDX is priced at $0.25, while IPDQF trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas IPDQF's P/E ratio is -2.50. In terms of profitability, CYDX's ROE is +0.17%, compared to IPDQF's ROE of -0.39%. Regarding short-term risk, CYDX and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, BLOZF has a market cap of 49M. Regarding current trading prices, CYDX is priced at $0.25, while BLOZF trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas BLOZF's P/E ratio is -21.28. In terms of profitability, CYDX's ROE is +0.17%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, CYDX is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check BLOZF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, RDGL has a market cap of 48.1M. Regarding current trading prices, CYDX is priced at $0.25, while RDGL trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas RDGL's P/E ratio is -10.60. In terms of profitability, CYDX's ROE is +0.17%, compared to RDGL's ROE of -1.45%. Regarding short-term risk, CYDX is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check RDGL's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, BRNHF has a market cap of 42.3M. Regarding current trading prices, CYDX is priced at $0.25, while BRNHF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, CYDX's ROE is +0.17%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, CYDX and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, TLTFF has a market cap of 40.9M. Regarding current trading prices, CYDX is priced at $0.25, while TLTFF trades at $0.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas TLTFF's P/E ratio is -16.29. In terms of profitability, CYDX's ROE is +0.17%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, CYDX is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check TLTFF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, NVYTF has a market cap of 35.4M. Regarding current trading prices, CYDX is priced at $0.25, while NVYTF trades at $0.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas NVYTF's P/E ratio is -0.68. In terms of profitability, CYDX's ROE is +0.17%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, CYDX is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check NVYTF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ELXMF has a market cap of 28.5M. Regarding current trading prices, CYDX is priced at $0.25, while ELXMF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, CYDX's ROE is +0.17%, compared to ELXMF's ROE of -0.39%. Regarding short-term risk, CYDX and ELXMF have similar daily volatility (0.00).Check ELXMF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, CYDX is priced at $0.25, while MKEAF trades at $0.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, CYDX's ROE is +0.17%, compared to MKEAF's ROE of +0.47%. Regarding short-term risk, CYDX and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, CYDX is priced at $0.25, while KBBTF trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, CYDX's ROE is +0.17%, compared to KBBTF's ROE of N/A. Regarding short-term risk, CYDX and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, EMITF has a market cap of 23.9M. Regarding current trading prices, CYDX is priced at $0.25, while EMITF trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas EMITF's P/E ratio is -12.00. In terms of profitability, CYDX's ROE is +0.17%, compared to EMITF's ROE of -0.08%. Regarding short-term risk, CYDX is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check EMITF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, POSC has a market cap of 22.7M. Regarding current trading prices, CYDX is priced at $0.25, while POSC trades at $1.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas POSC's P/E ratio is 0.32. In terms of profitability, CYDX's ROE is +0.17%, compared to POSC's ROE of +9.25%. Regarding short-term risk, CYDX is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check POSC's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, GTHP has a market cap of 20.6M. Regarding current trading prices, CYDX is priced at $0.25, while GTHP trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas GTHP's P/E ratio is -5.23. In terms of profitability, CYDX's ROE is +0.17%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, CYDX is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check GTHP's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, PYNKF has a market cap of 19.2M. Regarding current trading prices, CYDX is priced at $0.25, while PYNKF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas PYNKF's P/E ratio is -0.80. In terms of profitability, CYDX's ROE is +0.17%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, CYDX is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check PYNKF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, CYDX is priced at $0.25, while DIZTF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, CYDX's ROE is +0.17%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, CYDX is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check DIZTF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ASAPF has a market cap of 15M. Regarding current trading prices, CYDX is priced at $0.25, while ASAPF trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ASAPF's P/E ratio is -19.25. In terms of profitability, CYDX's ROE is +0.17%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, CYDX is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check ASAPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, MDXHF has a market cap of 14.2M. Regarding current trading prices, CYDX is priced at $0.25, while MDXHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, CYDX's ROE is +0.17%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, CYDX is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check MDXHF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, CYDX is priced at $0.25, while TMDIF trades at $0.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, CYDX's ROE is +0.17%, compared to TMDIF's ROE of -0.57%. Regarding short-term risk, CYDX is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check TMDIF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, VPTDF has a market cap of 13.6M. Regarding current trading prices, CYDX is priced at $0.25, while VPTDF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas VPTDF's P/E ratio is -4.07. In terms of profitability, CYDX's ROE is +0.17%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, CYDX is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check VPTDF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, CYDX is priced at $0.25, while PLLWF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, CYDX's ROE is +0.17%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, CYDX is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check PLLWF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, CYDX is priced at $0.25, while IMEXF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas IMEXF's P/E ratio is N/A. In terms of profitability, CYDX's ROE is +0.17%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, CYDX is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check IMEXF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, CYDX is priced at $0.25, while ATBPF trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, CYDX's ROE is +0.17%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, CYDX is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check ATBPF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, CYDX is priced at $0.25, while LXXGF trades at $0.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, CYDX's ROE is +0.17%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, CYDX and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, NGMDF has a market cap of 9.3M. Regarding current trading prices, CYDX is priced at $0.25, while NGMDF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas NGMDF's P/E ratio is -4.08. In terms of profitability, CYDX's ROE is +0.17%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, CYDX and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, FZMD has a market cap of 6.4M. Regarding current trading prices, CYDX is priced at $0.25, while FZMD trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas FZMD's P/E ratio is 1.44. In terms of profitability, CYDX's ROE is +0.17%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, CYDX and FZMD have similar daily volatility (0.00).Check FZMD's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, RMSL has a market cap of 6.1M. Regarding current trading prices, CYDX is priced at $0.25, while RMSL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas RMSL's P/E ratio is 0.40. In terms of profitability, CYDX's ROE is +0.17%, compared to RMSL's ROE of -2.86%. Regarding short-term risk, CYDX is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check RMSL's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, CYDX is priced at $0.25, while QLIS trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas QLIS's P/E ratio is 2.22. In terms of profitability, CYDX's ROE is +0.17%, compared to QLIS's ROE of -0.95%. Regarding short-term risk, CYDX and QLIS have similar daily volatility (0.00).Check QLIS's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, CYDX is priced at $0.25, while RHNMF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, CYDX's ROE is +0.17%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, CYDX is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check RHNMF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ODYY has a market cap of 4.6M. Regarding current trading prices, CYDX is priced at $0.25, while ODYY trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ODYY's P/E ratio is -0.32. In terms of profitability, CYDX's ROE is +0.17%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, CYDX is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check ODYY's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ALRTF has a market cap of 4.5M. Regarding current trading prices, CYDX is priced at $0.25, while ALRTF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ALRTF's P/E ratio is -0.24. In terms of profitability, CYDX's ROE is +0.17%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, CYDX and ALRTF have similar daily volatility (0.00).Check ALRTF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, VYCO has a market cap of 4.3M. Regarding current trading prices, CYDX is priced at $0.25, while VYCO trades at $0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas VYCO's P/E ratio is -13.00. In terms of profitability, CYDX's ROE is +0.17%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, CYDX and VYCO have similar daily volatility (0.00).Check VYCO's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, CYDX is priced at $0.25, while LBLTF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, CYDX's ROE is +0.17%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, CYDX is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check LBLTF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ADMT has a market cap of 4.1M. Regarding current trading prices, CYDX is priced at $0.25, while ADMT trades at $0.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ADMT's P/E ratio is -6.00. In terms of profitability, CYDX's ROE is +0.17%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, CYDX is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check ADMT's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, PMEDF has a market cap of 3.5M. Regarding current trading prices, CYDX is priced at $0.25, while PMEDF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas PMEDF's P/E ratio is -1.81. In terms of profitability, CYDX's ROE is +0.17%, compared to PMEDF's ROE of +0.80%. Regarding short-term risk, CYDX is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check PMEDF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, CYDX is priced at $0.25, while VANIW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas VANIW's P/E ratio is N/A. In terms of profitability, CYDX's ROE is +0.17%, compared to VANIW's ROE of -1.95%. Regarding short-term risk, CYDX is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check VANIW's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, BIEL has a market cap of 2.7M. Regarding current trading prices, CYDX is priced at $0.25, while BIEL trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas BIEL's P/E ratio is N/A. In terms of profitability, CYDX's ROE is +0.17%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, CYDX is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check BIEL's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, NUMD has a market cap of 2.7M. Regarding current trading prices, CYDX is priced at $0.25, while NUMD trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas NUMD's P/E ratio is 3.20. In terms of profitability, CYDX's ROE is +0.17%, compared to NUMD's ROE of +0.27%. Regarding short-term risk, CYDX and NUMD have similar daily volatility (0.00).Check NUMD's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, TBRIF has a market cap of 2.6M. Regarding current trading prices, CYDX is priced at $0.25, while TBRIF trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas TBRIF's P/E ratio is -0.75. In terms of profitability, CYDX's ROE is +0.17%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, CYDX is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check TBRIF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, USAQ has a market cap of 2.1M. Regarding current trading prices, CYDX is priced at $0.25, while USAQ trades at $0.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas USAQ's P/E ratio is -4.75. In terms of profitability, CYDX's ROE is +0.17%, compared to USAQ's ROE of +0.68%. Regarding short-term risk, CYDX is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check USAQ's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, ESMC has a market cap of 2M. Regarding current trading prices, CYDX is priced at $0.25, while ESMC trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas ESMC's P/E ratio is 5.40. In terms of profitability, CYDX's ROE is +0.17%, compared to ESMC's ROE of +0.31%. Regarding short-term risk, CYDX is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check ESMC's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, CYDX is priced at $0.25, while CRRVF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas CRRVF's P/E ratio is N/A. In terms of profitability, CYDX's ROE is +0.17%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, CYDX is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for CYDX.Check CRRVF's competition here

CYDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYDX stands at 1.3M. In comparison, LLBO has a market cap of 1.3M. Regarding current trading prices, CYDX is priced at $0.25, while LLBO trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYDX currently has a P/E ratio of 0.33, whereas LLBO's P/E ratio is N/A. In terms of profitability, CYDX's ROE is +0.17%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, CYDX and LLBO have similar daily volatility (0.00).Check LLBO's competition here